Mednet Logo
HomeRadiation OncologyQuestion

What is your cochlear dose constraint when treating acoustic neuromas with SRS in a patient with intact hearing?

3
1 Answers
Mednet Member
Mednet Member
Radiation Oncology · Stony Brook University School of Medicine

The critical components of hearing susceptible to radiation toxicity of vestibular schwannoma treatment include acoustic nerve, cochlea, and brain stem. It is unclear which structure is responsible. It helps to understand the continuum of fibers from the endolymphatic receptors from cochlea to form ...

Register or Sign In to see full answer

What is your cochlear dose constraint when treating acoustic neuromas with SRS in a patient with intact hearing? | Mednet